Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 2,947 | 2,163 | 1,234 | 1,363 | 1,256 |
| Cost of Goods | 1,415 | 1,197 | 904 | 700 | 682 |
| Gross Profit | 1,532 | 966 | 331 | 663 | 575 |
| Operating Expenses | 5,714 | 3,566 | 6,691 | 3,920 | 5,318 |
| Operating Income | -3,767 | -2,403 | -5,457 | -2,557 | -4,061 |
| Interest Expense | 64 | 76 | 73 | 66 | 70 |
| Other Income | 2,150 | 7,214 | 1,484 | 10,040 | 10,380 |
| Pre-tax Income | -1,681 | 4,735 | -4,046 | 7,417 | 6,248 |
| Income Tax | N/A | 3 | N/A | N/A | N/A |
| Net Income Continuous | -1,681 | 4,732 | -4,043 | 7,417 | 6,248 |
| Net Income | $-1,681 | $4,732 | $-4,043 | $7,417 | $6,248 |
| EPS Basic Total Ops | -0.01 | 0.02 | -0.01 | 0.03 | 0.04 |
| EPS Basic Continuous Ops | 0.00 | 0.01 | -0.01 | 0.01 | 0.01 |
| EPS Diluted Total Ops | -0.01 | 0.00 | 0.01 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | 0.01 | -0.01 | 0.01 | 0.01 |
| EBITDA(a) | $-3,603 | $-2,242 | $-5,524 | $-2,344 | $-3,835 |